Salvigenin

Salvigenin is a naturally occurring O-methylated flavone found in plants such as Salvia officinalis and Artemisia species, characterized by a trimethoxylated flavone backbone. It exerts its primary effects through modulation of autophagy pathways, apoptotic signaling cascades, and lipid metabolism enzymes in preclinical models.

Origin & History

Salvigenin is a naturally occurring trimethoxyflavone found in flavonoid-rich plants, functioning as a secondary metabolite. It is available as a yellow powder, soluble in DMSO, chloroform, and ethyl acetate, with a melting point of 188°C.

Historical & Cultural Context

There are no documented traditional or historical medicinal uses of salvigenin. The research does not provide insights into its historical or cultural context.

Health Benefits

• Potential autophagy inducer, though research is limited to preclinical studies.
• May act as an apoptosis inhibitor, supported by preliminary in-vitro evidence.
• Shows promise as an antilipemic agent in animal studies.
• Functions as an immunomodulator, as suggested by early-stage research.
• Exhibits neuroprotective properties, demonstrated in preclinical models.

How It Works

Salvigenin modulates the mTOR-AMPK signaling axis to influence autophagic flux, promoting or inhibiting autophagosome formation depending on cellular context. It interacts with Bcl-2 family proteins, particularly by influencing Bcl-2 and Bax expression ratios, thereby regulating mitochondrial-mediated apoptotic pathways. Additionally, salvigenin has been shown to inhibit HMG-CoA reductase activity and downregulate SREBP-1c transcription in hepatic cell models, contributing to its observed antilipemic effects.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted for salvigenin. Current knowledge is based solely on preclinical studies, lacking specific PMIDs or study details.

Clinical Summary

All available evidence for salvigenin derives from in-vitro cell culture studies and rodent animal models, with no registered human clinical trials identified as of 2024. Animal studies examining its antilipemic properties have demonstrated reductions in total cholesterol and LDL levels in hyperlipidemic mouse models, though sample sizes are typically small (n=10–20 per group) and study durations short. In-vitro apoptosis and autophagy studies have used cancer cell lines such as HeLa and MCF-7, reporting IC50 values in the low micromolar range (1–20 µM), but these concentrations have not been validated in human pharmacokinetic contexts. The overall evidence base is preliminary, and extrapolation to human therapeutic use is not currently supported.

Nutritional Profile

Salvigenin (5-hydroxy-6,7,4'-trimethoxyflavone) is a pure bioactive flavone compound, not a whole food ingredient, and therefore does not contain macronutrients (carbohydrates, proteins, fats), dietary fiber, or conventional micronutrients such as vitamins or minerals in any nutritional sense. As an isolated polyphenolic compound with molecular weight of 330.33 g/mol and molecular formula C18H18O6, its profile is defined entirely by its bioactive chemistry. It is a O-methylated flavone derivative found naturally in plants such as Salvia officinalis, Rosmarinus officinalis, and related Lamiaceae species, typically present in those source plants at concentrations ranging from trace levels to approximately 0.01–0.5% dry weight depending on plant part and extraction method. Bioavailability data for salvigenin specifically is limited; however, as a methoxylated flavone, the presence of methoxy groups at positions 6, 7, and 4' generally confers greater lipophilicity compared to hydroxylated flavones, suggesting enhanced passive intestinal absorption relative to polyhydroxylated counterparts. Estimated log P values for similar methoxyflavones suggest moderate lipid solubility (log P approximately 2.5–3.5), which may facilitate membrane permeability. No established dietary reference intake exists. Research doses in preclinical models have ranged from approximately 10–100 mg/kg body weight in animal studies. As a compound rather than a food, it contributes no caloric value and no known essential nutrient function.

Preparation & Dosage

No clinically studied dosage ranges or forms are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Resveratrol, Curcumin, Quercetin, Green Tea Extract, Berberine

Safety & Interactions

No human safety data or toxicology trials exist for isolated salvigenin supplementation, making definitive safety profiling impossible at this time. Animal studies have not reported overt acute toxicity at tested doses, but chronic exposure data are absent. Salvigenin's inhibition of cytochrome P450 enzymes, particularly CYP1A2 and CYP3A4, observed in in-vitro assays, raises theoretical concerns about interactions with drugs metabolized by these pathways, including statins, warfarin, and certain antiretrovirals. Pregnant and breastfeeding individuals should avoid supplementation due to a complete absence of reproductive safety data.